Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMSC01 in Multiple Sclerosis
NCT05532943Phase 2Recruiting
- Sponsor
- Ever Supreme Bio-Technology
- Start
- Sep 2023
- Primary completion
- Oct 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in multiple sclerosis (MS), sponsored by Ever Supreme Bio-Technology. Started Sep 2023; status: recruiting.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT05532943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05532943.